Clinical characteristics and prognosis of patients treated as invasive pulmonary aspergillosis outside of severe immunosuppression

Abstract This study aimed to identify clinical characteristics and develop a prognostic model for non-neutropenic patients with invasive pulmonary aspergillosis (IPA). A retrospective analysis of 151 IPA patients was conducted, with patients categorized into survival (n = 117) and death (n = 34) gro...

Full description

Saved in:
Bibliographic Details
Main Authors: Furui Liu, Wenling Chen, Honglei Qi, Yonghong Yang, Ying Yang, Zhaojun Wang, Jinyuan Zhu
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-87605-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571712974094336
author Furui Liu
Wenling Chen
Honglei Qi
Yonghong Yang
Ying Yang
Zhaojun Wang
Jinyuan Zhu
author_facet Furui Liu
Wenling Chen
Honglei Qi
Yonghong Yang
Ying Yang
Zhaojun Wang
Jinyuan Zhu
author_sort Furui Liu
collection DOAJ
description Abstract This study aimed to identify clinical characteristics and develop a prognostic model for non-neutropenic patients with invasive pulmonary aspergillosis (IPA). A retrospective analysis of 151 IPA patients was conducted, with patients categorized into survival (n = 117) and death (n = 34) groups. Clinical data, including demographics, laboratory tests, and imaging, were collected. Multivariate Cox regression analysis identified glucocorticoid use (odds ratio [OR] = 30.223, 95% confidence interval [CI]: 2.676–341.306), intensive care unit admission (OR = 0.133, 95% CI: 0.023–0.758), and the arterial oxygen partial pressure/fractional inspired oxygen ratio (OR = 0.994, 95% CI: 0.990–0.999) as significant predictors of 28-day mortality. A prognostic model was developed based on these factors, showing high predictive accuracy (receiver operating characteristic curve area of 0.918). The model’s clinical applicability was validated through calibration curves, bootstrap internal validation, decision curve analysis, and clinical impact curves. Kaplan–Meier analysis further confirmed its utility, indicating a worse prognosis for high-risk patients within 50 days and the highest survival rate at 14 days. This novel model offers valuable insights for predicting survival in non-neutropenic IPA patients.
format Article
id doaj-art-33d42d34409b4ef8827a5a0fcf9f4a0d
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-33d42d34409b4ef8827a5a0fcf9f4a0d2025-02-02T12:20:41ZengNature PortfolioScientific Reports2045-23222025-01-0115111110.1038/s41598-025-87605-4Clinical characteristics and prognosis of patients treated as invasive pulmonary aspergillosis outside of severe immunosuppressionFurui Liu0Wenling Chen1Honglei Qi2Yonghong Yang3Ying Yang4Zhaojun Wang5Jinyuan Zhu6The First School of Clinical Medicine, Ningxia Medical UniversityThe First School of Clinical Medicine, Ningxia Medical UniversityThe First School of Clinical Medicine, Ningxia Medical UniversityThe First School of Clinical Medicine, Ningxia Medical UniversityThe First School of Clinical Medicine, Ningxia Medical UniversityDepartment of Critical Care Medicine, General Hospital of Ningxia Medical UniversityDepartment of Critical Care Medicine, General Hospital of Ningxia Medical UniversityAbstract This study aimed to identify clinical characteristics and develop a prognostic model for non-neutropenic patients with invasive pulmonary aspergillosis (IPA). A retrospective analysis of 151 IPA patients was conducted, with patients categorized into survival (n = 117) and death (n = 34) groups. Clinical data, including demographics, laboratory tests, and imaging, were collected. Multivariate Cox regression analysis identified glucocorticoid use (odds ratio [OR] = 30.223, 95% confidence interval [CI]: 2.676–341.306), intensive care unit admission (OR = 0.133, 95% CI: 0.023–0.758), and the arterial oxygen partial pressure/fractional inspired oxygen ratio (OR = 0.994, 95% CI: 0.990–0.999) as significant predictors of 28-day mortality. A prognostic model was developed based on these factors, showing high predictive accuracy (receiver operating characteristic curve area of 0.918). The model’s clinical applicability was validated through calibration curves, bootstrap internal validation, decision curve analysis, and clinical impact curves. Kaplan–Meier analysis further confirmed its utility, indicating a worse prognosis for high-risk patients within 50 days and the highest survival rate at 14 days. This novel model offers valuable insights for predicting survival in non-neutropenic IPA patients.https://doi.org/10.1038/s41598-025-87605-4Non-neutropeniaInvasive pulmonary aspergillusMortalityPrognosis
spellingShingle Furui Liu
Wenling Chen
Honglei Qi
Yonghong Yang
Ying Yang
Zhaojun Wang
Jinyuan Zhu
Clinical characteristics and prognosis of patients treated as invasive pulmonary aspergillosis outside of severe immunosuppression
Scientific Reports
Non-neutropenia
Invasive pulmonary aspergillus
Mortality
Prognosis
title Clinical characteristics and prognosis of patients treated as invasive pulmonary aspergillosis outside of severe immunosuppression
title_full Clinical characteristics and prognosis of patients treated as invasive pulmonary aspergillosis outside of severe immunosuppression
title_fullStr Clinical characteristics and prognosis of patients treated as invasive pulmonary aspergillosis outside of severe immunosuppression
title_full_unstemmed Clinical characteristics and prognosis of patients treated as invasive pulmonary aspergillosis outside of severe immunosuppression
title_short Clinical characteristics and prognosis of patients treated as invasive pulmonary aspergillosis outside of severe immunosuppression
title_sort clinical characteristics and prognosis of patients treated as invasive pulmonary aspergillosis outside of severe immunosuppression
topic Non-neutropenia
Invasive pulmonary aspergillus
Mortality
Prognosis
url https://doi.org/10.1038/s41598-025-87605-4
work_keys_str_mv AT furuiliu clinicalcharacteristicsandprognosisofpatientstreatedasinvasivepulmonaryaspergillosisoutsideofsevereimmunosuppression
AT wenlingchen clinicalcharacteristicsandprognosisofpatientstreatedasinvasivepulmonaryaspergillosisoutsideofsevereimmunosuppression
AT hongleiqi clinicalcharacteristicsandprognosisofpatientstreatedasinvasivepulmonaryaspergillosisoutsideofsevereimmunosuppression
AT yonghongyang clinicalcharacteristicsandprognosisofpatientstreatedasinvasivepulmonaryaspergillosisoutsideofsevereimmunosuppression
AT yingyang clinicalcharacteristicsandprognosisofpatientstreatedasinvasivepulmonaryaspergillosisoutsideofsevereimmunosuppression
AT zhaojunwang clinicalcharacteristicsandprognosisofpatientstreatedasinvasivepulmonaryaspergillosisoutsideofsevereimmunosuppression
AT jinyuanzhu clinicalcharacteristicsandprognosisofpatientstreatedasinvasivepulmonaryaspergillosisoutsideofsevereimmunosuppression